<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="Sciences : Microbiology : Medical Microbiology : Microbial Pathogens :" exact="Viral" post="Pathogens : Immunodeficiency Viruses: HIV : Medicine and Health"/>
 <result pre=": Medical Microbiology : Microbial Pathogens : Viral Pathogens :" exact="Immunodeficiency" post="Viruses: HIV : Medicine and Health Sciences : Pathology"/>
 <result pre="Pathology and Laboratory Medicine : Pathogens : Microbial Pathogens :" exact="Viral" post="Pathogens : Immunodeficiency Viruses: HIV : Biology and Life"/>
 <result pre="Medicine : Pathogens : Microbial Pathogens : Viral Pathogens :" exact="Immunodeficiency" post="Viruses: HIV : Biology and Life Sciences : Organisms"/>
 <result pre=": Biology and Life Sciences : Organisms : Viruses :" exact="Viral" post="Pathogens : Immunodeficiency Viruses: HIV : Biology and Life"/>
 <result pre="Life Sciences : Organisms : Viruses : Viral Pathogens :" exact="Immunodeficiency" post="Viruses: HIV : Biology and Life Sciences : Organisms"/>
 <result pre=": Biology and Life Sciences : Organisms : Viruses :" exact="Immunodeficiency" post="Viruses: HIV : Biology and life sciences : Organisms"/>
 <result pre="Sciences : Microbiology : Medical Microbiology : Microbial Pathogens :" exact="Viral" post="Pathogens : Retroviruses : Lentivirus: HIV : Medicine and"/>
 <result pre="Pathology and Laboratory Medicine : Pathogens : Microbial Pathogens :" exact="Viral" post="Pathogens : Retroviruses : Lentivirus: HIV : Biology and"/>
 <result pre=": Biology and Life Sciences : Organisms : Viruses :" exact="Viral" post="Pathogens : Retroviruses : Lentivirus: HIV : Medicine and"/>
 <result pre=": Biology and Life Sciences : Microbiology : Virology :" exact="Viral" post="Transmission and Infection: Viral Load Impact of viral suppression"/>
 <result pre="Sciences : Microbiology : Virology : Viral Transmission and Infection:" exact="Viral" post="Load Impact of viral suppression among persons with HIV"/>
 <result pre="Virology : Viral Transmission and Infection: Viral Load Impact of" exact="viral" post="suppression among persons with HIV upon estimated HIV incidence"/>
 <result pre="between 2010 and 2015 in the United States Impact of" exact="viral" post="suppression among persons with HIV on HIV incidence 2010-2015"/>
 <result pre="review &amp;amp; editingSiddiqiAzfar-e-AlamConceptualizationData curationMethodologyWriting â€&quot; review &amp;amp; editing[], Division of" exact="HIV/AIDS" post="Prevention, Centers for Disease Control &amp;amp; Prevention, Atlanta, Georgia,"/>
 <result pre="â€&quot; review &amp;amp; editing[], Division of HIV/AIDS Prevention, Centers for" exact="Disease" post="Control &amp;amp; Prevention, Atlanta, Georgia, United States of AmericaHearpsAnna"/>
 <result pre="the population level. We investigated the impact of state level" exact="viral" post="suppression among PWH in the United States on estimated"/>
 <result pre="States on estimated HIV incidence between 2010 and 2015. Methods" exact="Viral" post="suppression data and HIV incidence estimates from the National"/>
 <result pre="District of Columbia. We assumed a one year delay for" exact="viral" post="suppression to impact incidence. Poisson regression models were used"/>
 <result pre="status, percent men who have sex with men (MSM) and" exact="hepatitis C" post="virus prevalence as a proxy for injection drug use"/>
 <result pre="incidence by far throughout this period but upon adjustment for" exact="viral" post="suppression and demographics there was a 36% lower incidence"/>
 <result pre="adjustment for viral suppression and demographics there was a 36%" exact="lower" post="incidence rate than Northeast states (adjusted rate ratio [aRR]"/>
 <result pre="0.42, 0.99). For every 10 percentage point (pp) increase in" exact="viral" post="suppression there was an adjusted 4% decline in HIV"/>
 <result pre="subsequent year (aRR 0.96; 95%CI 0.93, 0.99). While controlling for" exact="viral" post="suppression, HIV incidence rate increased by 42% (aRR 1.42"/>
 <result pre="HIV incidence from 2010 to 2015 was associated with increasing" exact="viral" post="suppression in the United States. Race and sexual orientation"/>
 <result pre="States in 1996. Shortly thereafter the United States Centers for" exact="Disease" post="Control and Prevention (CDC) reported the first substantial decline"/>
 <result pre="in this trial occurred from HIV-infected participants whose last index" exact="viral" post="load before the estimated date of infection of their"/>
 <result pre="whose last index viral load before the estimated date of" exact="infection" post="of their uninfected partners exceeded 40,000 copies/mL [6]. Similar"/>
 <result pre="uninfected partners exceeded 40,000 copies/mL [6]. Similar associations between reduced" exact="viral" post="load and reduced HIV incidence were observed in British"/>
 <result pre="1% decline in HIV incidence for every 1% increase in" exact="viral" post="suppression [7]. The authors concluded that ART expansion between"/>
 <result pre="[8]. In the United States, a Poisson model using â€œcommunity" exact="viral" post="loadâ€� in the city of San Francisco showed that"/>
 <result pre="the city of San Francisco showed that an increase in" exact="viral" post="suppression from 45% to 78% was associated with a"/>
 <result pre="HIV between 2004 and 2008 [9]. However, the impact of" exact="viral" post="suppression on incident HIV has not been previously reported"/>
 <result pre="Over the past decade, jurisdictions have increasingly provided reports of" exact="viral" post="load data from persons living with diagnosed HIV and"/>
 <result pre="by jurisdiction. In this paper, we examined the impact of" exact="viral" post="suppression on estimated incident HIV by jurisdiction in the"/>
 <result pre="(NHSS) serves as the source for both HIV diagnosis and" exact="viral" post="suppression data. CDC estimates and publishes HIV incidence using"/>
 <result pre="al. using a CD4 depletion model to estimate time between" exact="infection" post="and diagnosis [10, 11]. The estimation method also makes"/>
 <result pre="below poverty level. These demographic data were extracted from the" exact="American" post="Community Survey and the Current Population Survey [14, 15]."/>
 <result pre="MSM. We included published estimates of percentage of MSM among" exact="adult" post="men for each state [16]. Recent increases in injection"/>
 <result pre="drug use in the United States has resulted in growing" exact="hepatitis C" post="(HCV) and HIV infections in some rural areas. In"/>
 <result pre="States has resulted in growing hepatitis C (HCV) and HIV" exact="infections" post="in some rural areas. In this study, we also"/>
 <result pre="areas. In this study, we also included prevalence of HCV" exact="infection" post="by state in the analysis as a proxy for"/>
 <result pre="based on National Health and Nutrition Examination Survey 2009â€&quot;2013 [17]." exact="Viral" post="suppression among persons living with HIV (diagnosed and undiagnosed)"/>
 <result pre="numbers. The numerator was the number of persons with suppressed" exact="viral" post="load test results reported to CDC from jurisdictions with"/>
 <result pre="viral load test results reported to CDC from jurisdictions with" exact="complete" post="laboratory reporting of CD4 and viral load test results."/>
 <result pre="CDC from jurisdictions with complete laboratory reporting of CD4 and" exact="viral" post="load test results. Standard surveillance definition of &amp;lt;200 copies/mL"/>
 <result pre="recent test result in each year, was used to define" exact="viral" post="suppression in a given calendar year. The denominator consisted"/>
 <result pre="in a given calendar year. The denominator consisted of estimated" exact="total" post="prevalence of HIV for the same year, count of"/>
 <result pre="surveillance supplemental reports [12, 13]. or the National Center for" exact="HIV/AIDS" post="Viral Hepatitis STD and Tuberculosis Preventionâ€™s AtlasPlus, available at"/>
 <result pre="supplemental reports [12, 13]. or the National Center for HIV/AIDS" exact="Viral" post="Hepatitis STD and Tuberculosis Preventionâ€™s AtlasPlus, available at https://www.cdc.gov/nchhstp/atlas/index.htm."/>
 <result pre="reports [12, 13]. or the National Center for HIV/AIDS Viral" exact="Hepatitis" post="STD and Tuberculosis Preventionâ€™s AtlasPlus, available at https://www.cdc.gov/nchhstp/atlas/index.htm. To"/>
 <result pre="or the National Center for HIV/AIDS Viral Hepatitis STD and" exact="Tuberculosis" post="Preventionâ€™s AtlasPlus, available at https://www.cdc.gov/nchhstp/atlas/index.htm. To assess the impact"/>
 <result pre="Preventionâ€™s AtlasPlus, available at https://www.cdc.gov/nchhstp/atlas/index.htm. To assess the impact of" exact="viral" post="suppression on estimated HIV incidence between 2011 and 2015,"/>
 <result pre="HIV incidence between 2011 and 2015, a one-year lag in" exact="viral" post="suppression was used thereby restricting the viral suppression data"/>
 <result pre="one-year lag in viral suppression was used thereby restricting the" exact="viral" post="suppression data in our analysis to the 2010â€&quot;2014 time"/>
 <result pre="data in our analysis to the 2010â€&quot;2014 time frame. Although" exact="viral" post="suppression data were available for 39 jurisdictions for at"/>
 <result pre="time. Means and standard deviations were used to summarize percent" exact="viral" post="suppression and state level demographic variables by year. Quartiles"/>
 <result pre="by year. Quartiles for estimated HIV incidence rate and percent" exact="viral" post="suppression were calculated across the entire time frame, and"/>
 <result pre="Unadjusted and adjusted rate ratios associated with differences in percent" exact="viral" post="suppression and demographic characteristics were calculated using multivariable mixed-effects"/>
 <result pre="and a random intercept to account for within-state correlations. Percent" exact="viral" post="suppression and state level demographics were treated as continuous"/>
 <result pre="21.8) respectively. 10.1371/journal.pone.0240727.t001Table 1 Estimated HIV incidence rate, state level" exact="viral" post="suppression and demographics by year for 29 states and"/>
 <result pre="16.6 16.1 15.6 15.7 15.6 -8.7 Mean (standard deviation) Percent" exact="Viral" post="Suppression 32.3 (6.6) 36.2 (5.9) 40.2 (6.4) 45.4 (7.6)"/>
 <result pre="(standard deviation) Percent MSM 2009â€&quot;13Â¶ 3.5 (2.5) Prevalence of HCV" exact="Infection" post="2013â€&quot;16Â¶ 0.9 (0.4) Regionâ€ Â¶ Â Â Â Â"/>
 <result pre="(7 states) * States were included in the subset if" exact="viral" post="suppression data was available for 60% of study years,"/>
 <result pre="Utah, Washington, Wyoming). Â¶ Percent MSM and prevalence of HCV" exact="infection" post="were estimated from the noted data sources over the"/>
 <result pre="sources include: National HIV Surveillance System (estimated HIV incidence and" exact="viral" post="suppression for persons with HIV); American Community Survey 2010â€&quot;15"/>
 <result pre="(estimated HIV incidence and viral suppression for persons with HIV);" exact="American" post="Community Survey 2010â€&quot;15 (percent less than high school graduate,"/>
 <result pre="(percent below poverty level); published estimates using data from the" exact="American" post="Community Survey 2009â€&quot;2013 (percent men who have sex with"/>
 <result pre="2015 with 2010, most states and DC either began reporting" exact="viral" post="suppression data or had improvements in the proportion of"/>
 <result pre="(Fig 2). Most states did not experience changes to a" exact="lower" post="quartile of estimated HIV incidence rate, although one populous"/>
 <result pre="did two others (Minnesota and Oregon). Overall mean (Â±standard deviation)" exact="viral" post="suppression among PWH steadily increased from 32.3% Â± 6.6%"/>
 <result pre="2015 (Table 1) for the 30 jurisdictions. Fig 2 Percentage" exact="viral" post="suppression in persons with HIV and estimated HIV incidence"/>
 <result pre="30 jurisdictions (29 states and the District of Columbia) with" exact="viral" post="suppression data available for 3 years or more. Estimated"/>
 <result pre="3 years or more. Estimated HIV incidence rate and percent" exact="viral" post="suppression categories were determined by quartiles calculated across the"/>
 <result pre="South (Fig 1). Fig 3 Fitted HIV incidence rate by" exact="viral" post="suppression in previous year (%) and U.S. region, 2011â€&quot;2015."/>
 <result pre="adjusted associations of estimated HIV incidence rate with state level" exact="viral" post="suppression and demographic variables. Unadjusted Rate Ratio* Adjusted Rate"/>
 <result pre="Ratio* Adjusted Rate Ratioâ€ (95% CI) p-value (95% CI) p-value" exact="Viral" post="Suppression (%) in previous year 1.02 (0.99, 1.05) 0.117"/>
 <result pre="1.48) 0.002 (per increase of 1 pp) Prevalence of HCV" exact="Infection" post="2013â€&quot;16 2.83 (1.58, 5.09) &amp;lt; 0.001 1.00 (0.69, 1.44)"/>
 <result pre="incidence rate for every 10 percentage point (pp) increase in" exact="viral" post="suppression (adjusted rate ratio [aRR] = 0.96; 95% confidence"/>
 <result pre="interval (CI) = 0.93, 0.99, Table 3). While adjusting for" exact="viral" post="suppression and relevant state level demographic characteristics, every 5"/>
 <result pre="CI 1.07, 1.14; respectively). For every 1 pp increase in" exact="adult" post="men who were MSM, there was a 27% increase"/>
 <result pre="5 pp increase in percent uninsured. The largest impact of" exact="viral" post="suppression after adjusting for relevant state level demographic characteristics"/>
 <result pre="(95% CI 0.49, 1.06). Fig 3 suggests that if percent" exact="viral" post="suppression increased from 30% to 50%, the fitted incidence"/>
 <result pre="and the District of Columbia every 10 pp increase in" exact="viral" post="suppression during the previous year was associated with an"/>
 <result pre="in HIV incidence rate for every 10 pp increase in" exact="viral" post="suppression, respectively. Our ecologic analysis is remarkable considering that"/>
 <result pre="to make the greatest impact on incident HIV with better" exact="viral" post="suppression of PWH. In 2014, Southern states account for"/>
 <result pre="percentage uninsured, particularly in 2014 and 2015. After adjustment for" exact="viral" post="suppression and demographic characteristics, HIV incidence rate was 36%"/>
 <result pre="viral suppression and demographic characteristics, HIV incidence rate was 36%" exact="lower" post="in Southern states compared to northeastern states. While health"/>
 <result pre="30.8% [20]. This observation suggests a possible link between reduced" exact="viral" post="suppression among privately insured diagnosed PWH and HIV incidence"/>
 <result pre="education, unstable housing, inadequate health insurance, disproportionate incarceration rates and" exact="limited" post="social mobility [21â€&quot;23]. Additionally, gay and bisexual men accounted"/>
 <result pre="of these new diagnoses in MSM, 38% were among Black/African" exact="American" post="persons. Rather than geographic region being the explanatory variable,"/>
 <result pre="Northeastern states. We observed a trend of overall increases in" exact="viral" post="suppression and decreased HIV incidence across the United States."/>
 <result pre="management, transportation, pharmacy services) were provided by the Ryan White" exact="HIV/AIDS" post="Program (RWHAP), a federal program established in 1990 to"/>
 <result pre="between HIV incidence, insurance and poverty. While controlling for percent" exact="viral" post="suppression, our analysis showed a 10% increase in the"/>
 <result pre="a recent analysis of the RWHAP showed that, among recipients," exact="viral" post="suppression increased from 69.5% in 2010 to 85.9% in"/>
 <result pre="to assess whether injection drug use impacted the relationship between" exact="viral" post="suppression and HIV incidence. We included HCV prevalence by"/>
 <result pre="model as a proxy for injection drug use because HCV" exact="infection" post="is strongly associated with injection drug use. We did"/>
 <result pre="being that by 2015 not all states were reporting all" exact="viral" post="load and CD4+ lymphocyte test results data. Even some"/>
 <result pre="of the 30 jurisdictions in our subset did not have" exact="viral" post="suppression data for all years between 2010 and 2015,"/>
 <result pre="Another limitation is that we used a single measure of" exact="viral" post="load to determine who was or was not virally"/>
 <result pre="was or was not virally suppressed; however single measures of" exact="viral" post="load do not necessarily approximate durable viral suppression [29]."/>
 <result pre="single measures of viral load do not necessarily approximate durable" exact="viral" post="suppression [29]. While some analyses examined the impact of"/>
 <result pre="of our analysis is the examination of the use of" exact="viral" post="suppression to impact HIV incidence rather than ART coverage"/>
 <result pre="transmissions were generated by persons who were aware of their" exact="HIV infection" post="but were not in care, and 38% of new"/>
 <result pre="were generated by persons who were aware of their HIV" exact="infection" post="but were not in care, and 38% of new"/>
 <result pre="infection but were not in care, and 38% of new" exact="infections" post="were generated by persons unaware of their status [36]."/>
 <result pre="analysis suggests that between 2010 and 2015, the increase in" exact="viral" post="suppression observed after the rollout of ART was associated"/>
 <result pre="that include integrase inhibitors and single-tablet triple therapies have made" exact="viral" post="suppression easier than ever before. Based upon another ecologic"/>
 <result pre="ever before. Based upon another ecologic analysis that controlled for" exact="viral" post="suppression, PrEP may already have made a contribution towards"/>
 <result pre="of the RWHAP in helping uninsured and under-insured PWH achieve" exact="viral" post="suppression and thereby reduce incident HIV, and that the"/>
 <result pre="thereby reduce incident HIV, and that the greatest impact of" exact="viral" post="suppression may be effected in Southern states. The â€˜Ending"/>
 <result pre="not necessarily represent the views of the U.S. Centers for" exact="Disease" post="Control and Prevention. References References 1http://www.cdc.gov/media/pressrel/r981007.htm [Last accessed July"/>
 <result pre="Dis2004; 190:879â€&quot;85. 10.1086/42260115295691 5CohenMS, YingQC, McCauleyM, et al.Prevention of HIV-1" exact="infection" post="with early antiretroviral therapy. New Engl J Med2011; 364:1943â€&quot;54."/>
 <result pre="al.Expansion of HAART coverage is associated with sustained decreases in" exact="HIV/AIDS" post="morbidity, mortality and HIV transmission: the â€˜â€˜HIV Treatment as"/>
 <result pre="Setting. PLoS One2014; 9: e8787210.1371/journal.pone.008787224533061 8SolomonSS, MehtaSH, McFallAM, et al.Community" exact="viral" post="load, antiretroviral therapy coverage, and HIV incidence in India:"/>
 <result pre="HIV2016; 3: e183â€&quot;9010.1016/S2352-3018(16)00019-927036994 9DasM, ChuPL, SantosG-M, et al.Decreases in community" exact="viral" post="load are accompanied by reductions in new HIV infections"/>
 <result pre="community viral load are accompanied by reductions in new HIV" exact="infections" post="in San FranciscoPLoS One2010; 5: e1106810.1371/journal.pone.001106820548786 10LodiS, PhillipsA, TouloumiG,"/>
 <result pre="One2010; 5: e1106810.1371/journal.pone.001106820548786 10LodiS, PhillipsA, TouloumiG, et al.Time From Human" exact="Immunodeficiency" post="Virus Seroconversion to Reaching CD4+ Cell Count Thresholds &amp;lt;200,"/>
 <result pre="data to estimate HIV incidence, prevalence, and percent of undiagnosed" exact="infections" post="in the United States. J Acquir Immune Defic Syndr."/>
 <result pre="J Acquir Immune Defic Syndr. 2017;74:3â€&quot;9. 10.1097/QAI.000000000000115127509244 12collab: Centers for" exact="Disease" post="Control and Prevention. Monitoring selected national HIV prevention and"/>
 <result pre="areas, 2017. HIV Surveillance Supplemental Report2019;24(No. 3). 13collab: Centers for" exact="Disease" post="Control and Prevention. Estimated HIV incidence and prevalence in"/>
 <result pre="Men in US States and Counties Using Data From the" exact="American" post="Community Survey. JMIR Public Health Surveill. 2016;2(1):e1410.2196/publichealth.536527227149 17RosenbergES, RosenthalEM,"/>
 <result pre="Public Health Surveill. 2016;2(1):e1410.2196/publichealth.536527227149 17RosenbergES, RosenthalEM, HallEW, et al.Prevalence of" exact="Hepatitis" post="C Virus Infection in US States and the District"/>
 <result pre="2016;2(1):e1410.2196/publichealth.536527227149 17RosenbergES, RosenthalEM, HallEW, et al.Prevalence of Hepatitis C Virus" exact="Infection" post="in US States and the District of Columbia, 2013"/>
 <result pre="2013 to 2016. JAMA Netw Open. 2018;1(8):e18637110.1001/jamanetworkopen.2018.637130646319 18Abdool KarimSS. HIV-1" exact="Epidemic" post="Controlâ€&quot;Insights from Test-and-Treat Trials. N England J Med. 2019;"/>
 <result pre="the United Statesâ€&quot;2012â€&quot;2014. AIDS Care. 201830(9):1128â€&quot;1134. 10.1080/09540121.2018.148909929925249 21collab: Centers for" exact="Disease" post="Control and Prevention. Social determinants of health among adults"/>
 <result pre="and Prevention. Social determinants of health among adults with diagnosed" exact="HIV infection" post="in 20 states, the District of Columbia, and Puerto"/>
 <result pre="Prevention. Social determinants of health among adults with diagnosed HIV" exact="infection" post="in 20 states, the District of Columbia, and Puerto"/>
 <result pre="Disparities in the Health Resources and Services Administrationâ€™s Ryan White" exact="HIV/AIDS" post="Program. Am J Public Health2018; 108:S246â€&quot;250. 10.2105/AJPH.2018.30468930383416 25YehiaBR, FleishmanJA,"/>
 <result pre="Acquir Immune Defic Syndr. 2014; 67(1):102â€&quot;6. 10.1097/QAI.000000000000025124977377 26HRSA. Ryan White" exact="HIV/AIDS" post="Program Annual Client-Level Data Report 2017. http://hab.hrsa.gov/data/data-reports. Published December"/>
 <result pre="http://hab.hrsa.gov/data/data-reports. Published December 2018. 27BradleyH, ViallAH, WortleyPM, et al.Ryan White" exact="HIV/AIDS" post="Program assistance and HIV treatment outcomes. Clin Infect Dis2016;62:90â€&quot;8."/>
 <result pre="al.County-level vulnerability assessment for rapid dissemination of HIV or HCV" exact="infections" post="among persons who inject drugs, United States. J Acquir"/>
 <result pre="suppression patterns among persons in the United States with diagnosed" exact="HIV infection" post="in 2014Ann Intern Med2017; 167: 446â€&quot;7. 10.7326/L17-027828785761 30HallHI, FrazierEL,"/>
 <result pre="patterns among persons in the United States with diagnosed HIV" exact="infection" post="in 2014Ann Intern Med2017; 167: 446â€&quot;7. 10.7326/L17-027828785761 30HallHI, FrazierEL,"/>
 <result pre="167: 446â€&quot;7. 10.7326/L17-027828785761 30HallHI, FrazierEL, RhodesP, et al.Differences in human" exact="immunodeficiency" post="virus care and treatment among subpopulations in the United"/>
 <result pre="among subpopulations in the United StatesJAMA Intern Med2013 31Centers for" exact="Disease" post="Control and Prevention (2018). New CDC analysis shows steep"/>
 <result pre="of Increases in Pre-exposure Prophylaxis Coverage With Decreases in Human" exact="Immunodeficiency" post="Virus Diagnosis Rates in the United States, 2012â€&quot;2016Clin Infect"/>
</results>
